WASHINGTON, Feb. 2 -- Sen. Peter Welch issued the following press release:
U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, recently joined U.S. Senate Democratic Whip Dick Durbin (D-Ill.) and U.S. Senator Elizabeth Warren (D-Mass.) in urging the Department of Health and Human Services (HHS) Office of Inspector General (OIG) to review serious questions about the operations of TrumpRx, a new direct-to-consumer (DTC) prescription drug purchasing platform the Trump Administration plans to launch soon.
In their letter, the Senators warn that without stricter safeguards before its official launch, TrumpRx could be used as a potential vehicle for unlawful kickback schemes that result in excessive costs for the federal...